| Name | Heritage Park |
|---|---|
| Location | 2001 Hobson Rd, Fort Wayne, Indiana |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 180 |
| Occupancy Rate | 71.89% |
| Medicare ID (CCN) | 155095 |
| Legal Business Name | The Health And Hospital Corporation Of Marion County |
| Ownership Type | Government - County |
| NPI Number | 1396732780 |
| Organization Name | THE HEALTH AND HOSPITAL CORPORATION OF MARION COUNTY |
| Doing Business As | HERITAGE PARK |
| Address | 2001 Hobson Rd, Fort Wayne, IN 46805 |
| Phone Number | 260-484-9557 |
News Archive
Interventional radiology treatments re-establish blood flow in people with chronic deep vein thrombosis (DVT), reducing disabling symptoms and improving the quality of life for those afflicted with post-thrombotic syndrome—an under-recognized but frequent long-term complication of DVT.
Angiochem, Inc. a clinical-stage biotechnology company developing drugs that are uniquely capable of crossing the blood-brain barrier to treat brain diseases, announced today that its lead drug candidate, ANG1005, has demonstrated a favorable safety and efficacy profile in more than 100 patients with brain cancer from two separate Phase 1 /2 clinical studies in patients with progressive gliomas, including recurrent glioblastoma, and in patients with progressive brain metastases.
Wilson Therapeutics AB, a development stage biopharmaceutical company, today announced that a poster of the company's ongoing Phase 2 clinical trial for WTX101-201 will be presented at the upcoming annual meeting of the European Association for the Study of the Liver, or the 50th International Liver Congress 2015, taking place in Vienna April 22-26.
Patients undergoing major vascular surgery procedures are at increased risk of stroke, leading to a high mortality rate and prolonged hospitalization, according to a study in the February issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).
› Verified 8 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Interventional radiology treatments re-establish blood flow in people with chronic deep vein thrombosis (DVT), reducing disabling symptoms and improving the quality of life for those afflicted with post-thrombotic syndrome—an under-recognized but frequent long-term complication of DVT.
Angiochem, Inc. a clinical-stage biotechnology company developing drugs that are uniquely capable of crossing the blood-brain barrier to treat brain diseases, announced today that its lead drug candidate, ANG1005, has demonstrated a favorable safety and efficacy profile in more than 100 patients with brain cancer from two separate Phase 1 /2 clinical studies in patients with progressive gliomas, including recurrent glioblastoma, and in patients with progressive brain metastases.
Wilson Therapeutics AB, a development stage biopharmaceutical company, today announced that a poster of the company's ongoing Phase 2 clinical trial for WTX101-201 will be presented at the upcoming annual meeting of the European Association for the Study of the Liver, or the 50th International Liver Congress 2015, taking place in Vienna April 22-26.
Patients undergoing major vascular surgery procedures are at increased risk of stroke, leading to a high mortality rate and prolonged hospitalization, according to a study in the February issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).
› Verified 8 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 14.32 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 9.56 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 78.53 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.43 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 4.43 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 5.75 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 2.23 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 99.11 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 10.5 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 98.7 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 1.32 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 9.36 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 14.32 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 7.03 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 99.81 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 75.79 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 98.67 | 82.93 |
News Archive
Interventional radiology treatments re-establish blood flow in people with chronic deep vein thrombosis (DVT), reducing disabling symptoms and improving the quality of life for those afflicted with post-thrombotic syndrome—an under-recognized but frequent long-term complication of DVT.
Angiochem, Inc. a clinical-stage biotechnology company developing drugs that are uniquely capable of crossing the blood-brain barrier to treat brain diseases, announced today that its lead drug candidate, ANG1005, has demonstrated a favorable safety and efficacy profile in more than 100 patients with brain cancer from two separate Phase 1 /2 clinical studies in patients with progressive gliomas, including recurrent glioblastoma, and in patients with progressive brain metastases.
Wilson Therapeutics AB, a development stage biopharmaceutical company, today announced that a poster of the company's ongoing Phase 2 clinical trial for WTX101-201 will be presented at the upcoming annual meeting of the European Association for the Study of the Liver, or the 50th International Liver Congress 2015, taking place in Vienna April 22-26.
Patients undergoing major vascular surgery procedures are at increased risk of stroke, leading to a high mortality rate and prolonged hospitalization, according to a study in the February issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).
› Verified 8 days ago
Summit City Nursing And Rehabilitation Location: 2940 N Clinton St, Fort Wayne, Indiana 46805 Phone: (260) 484-0602 | |
Glenbrook Rehabilitation & Skilled Nursing Center Location: 3811 Parnell Ave, Fort Wayne, Indiana 46805 Phone: (260) 482-4651 | |
Signature Healthcare Of Fort Wayne Location: 6006 Brandy Chase Cove, Fort Wayne, Indiana 46815 Phone: (260) 486-3001 | |
Elevate Senior Living - Fort Wayne Location: 3420 East State Blvd, Fort Wayne, Indiana 46805 Phone: (260) 484-3120 | |
Life Care Center Of Fort Wayne Location: 1649 Spy Run Avenue, Fort Wayne, Indiana 46805 Phone: (260) 422-8520 |